Director/PDMR Shareholding

RNS Number : 8058H
Feedback PLC
19 November 2018
 

19 November 2018

Feedback plc

Director/PDMR Shareholdings

Cambridge, 19 November 2018: Further to the announcement on 15 November 2018, Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, announces the following changes to the interests of the Directors of the Company following the admission to trading on AIM of the New Ordinary Shares issued pursuant to the Subscription.  

Director/PDMR

Subscription Shares subscribed for

Total number of Ordinary Shares now held

% of Company's issued share capital





Dr Alastair Riddell

1,000,000

7,000,000

1.88

Lindsay Melvin

600,000

600,000

0.16

Simon Sturge

               5,333,333

12,833,333

3.44

 

Capitalised terms used but not defined in this announcement shall have the meanings given to such terms in the circular issued by the Company dated 25 October 2018 unless otherwise defined herein.

Enquiries:

 

Feedback plc

Alastair Riddell, Executive Chairman

Lindsay Melvin, CFO

 

+44 (0)1954 718072

IR@fbk.com

Allenby Capital Limited (Nominated Adviser)

David Worlidge / Asha Chotai

 

+44 (0)20 3328 5656

Peterhouse Capital Limited (Joint Broker)

Lucy Williams / Duncan Vasey

 

+44 (0)20 7469 0936

Stanford Capital Partners Limited (Joint Broker)

Patrick Claridge / John Howes

 

Instinctif Partners

Rozi Morris/ Deborah Bell/ Phillip Marriage

+44 20 3815 8880

 

 

+44 (0)20 7457 2020

feedbackplc@instinctif.com

 

Notes to editors

About Feedback plc 

Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer. Feedback Medical works with customers globally from headquarters in the internationally renowned scientific hub of Cambridge, UK. Its proprietary technologies are TexRAD®, the quantitative texture analysis tool and Cadran, a picture archiving communication system (PACS). For more information, see www.fbk.com

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHGGGAAGUPRGCB

Companies

Feedback (FDBK)
UK 100

Latest directors dealings